scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1177/2047487316663873 |
P698 | PubMed publication ID | 27600690 |
P50 | author | Ulf Landmesser | Q27235435 |
Christi Deaton | Q60398444 | ||
Ugo Corrà | Q63676759 | ||
Ines Frederix | Q64139107 | ||
Christiaan Vrints | Q66764574 | ||
Paul Dendale | Q85646420 | ||
Tina Birgitte Hansen | Q92529851 | ||
Catriona S Jennings | Q94472911 | ||
Antonio Pelliccia | Q96347890 | ||
Pantaleo Giannuzzi | Q114321792 | ||
Jean-Paul Schmid | Q114403008 | ||
David Walker | Q42645460 | ||
Margaret Cupples | Q52612608 | ||
Héctor Bueno | Q56435517 | ||
Donna Fitzsimons | Q57052635 | ||
Eva Prescott | Q60369768 | ||
P2093 | author name string | Patrick Doherty | |
Massimo F Piepoli | |||
Ian Graham | |||
Pedro Marques-Vidal | |||
P2860 | cites work | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) | Q22242892 |
Cardiac rehabilitation | Q26784405 | ||
A Randomized Trial of Intensive versus Standard Blood-Pressure Control | Q27231406 | ||
Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010 | Q28222464 | ||
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Q28281870 | ||
Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study | Q28732420 | ||
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet | Q29030043 | ||
Why don't physicians follow clinical practice guidelines? A framework for improvement | Q29619967 | ||
A reengineered hospital discharge program to decrease rehospitalization: a randomized trial | Q30228286 | ||
The hospitalist movement 5 years later | Q30799875 | ||
Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective | Q30884351 | ||
Rivaroxaban in patients with a recent acute coronary syndrome | Q34231902 | ||
Posthospital care transitions: patterns, complications, and risk identification | Q34336815 | ||
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes | Q34479098 | ||
Do practitioners and friends support patients with coronary heart disease in lifestyle change? a qualitative study | Q34975636 | ||
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents | Q35783487 | ||
Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. | Q35925690 | ||
Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension | Q35963841 | ||
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial | Q36305422 | ||
ACHTUNG-Rule: a new and improved model for prognostic assessment in myocardial infarction. | Q37140988 | ||
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program | Q37383851 | ||
Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. | Q37642525 | ||
Barriers to cardiovascular disease risk scoring and primary prevention in Europe | Q37777906 | ||
Effect of cardiac rehabilitation referral strategies on utilization rates: a prospective, controlled study | Q37843053 | ||
Why are we failing to implement effective therapies in cardiovascular disease? | Q38078726 | ||
Factors influencing referral to cardiac rehabilitation and secondary prevention programs: a systematic review. | Q38121063 | ||
The role of cardiac rehabilitation following acute coronary syndromes | Q38241098 | ||
Challenges in secondary prevention of cardiovascular diseases: a review of the current practice | Q38273332 | ||
A review of telerehabilitation for cardiac patients | Q38283147 | ||
Frailty Syndrome in cardiovascular disease: clinical significance and research tools. | Q38321188 | ||
Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes | Q38376003 | ||
Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network | Q38385771 | ||
Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey | Q38431041 | ||
Five year follow up of patients at high cardiovascular risk who took part in randomised controlled trial of health promotion | Q38639760 | ||
A polypill strategy to improve adherence: results from the FOCUS project | Q38934203 | ||
Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry | Q39203358 | ||
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Associati | Q39599004 | ||
Long-term use of ticagrelor in patients with prior myocardial infarction | Q40263764 | ||
Effect of comprehensive cardiac telerehabilitation on one-year cardiovascular rehospitalization rate, medical costs and quality of life: A cost-effectiveness analysis | Q40306699 | ||
ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients | Q41011613 | ||
Rehabilitation after myocardial infarction trial (RAMIT): multi-centre randomised controlled trial of comprehensive cardiac rehabilitation in patients following acute myocardial infarction | Q42629912 | ||
ESC core curriculum for the general cardiologist (2013). | Q43464217 | ||
Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy | Q45254779 | ||
Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised con | Q46538506 | ||
Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients | Q47432715 | ||
Short- and long-term cause of death in patients treated with primary PCI for STEMI. | Q48431119 | ||
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted | Q48527068 | ||
Length of stay has minimal impact on the cost of hospital admission | Q50133905 | ||
Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry. | Q51072839 | ||
Acute myocardial infarction | Q54069247 | ||
P433 | issue | 18 | |
P921 | main subject | myocardial infarction | Q12152 |
acute myocardial infarction | Q18558122 | ||
P304 | page(s) | 1994-2006 | |
P577 | publication date | 2016-09-06 | |
P1433 | published in | European Journal of Preventive Cardiology | Q2493290 |
P1476 | title | Challenges in secondary prevention after acute myocardial infarction: A call for action. | |
P478 | volume | 23 |
Q59794225 | All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with tr |
Q49622773 | Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994-2016. |
Q89471597 | Continuity of care and its associations with self-reported health, clinical characteristics and follow-up services after percutaneous coronary intervention |
Q93048189 | Different outcomes of a cardiac rehabilitation programme in functional parameters among myocardial infarction survivors according to ejection fraction |
Q92291935 | ESC Heart Failure receives its first impact factor |
Q64076998 | Evaluating the Impact of the HeartHab App on Motivation, Physical Activity, Quality of Life, and Risk Factors of Coronary Artery Disease Patients: Multidisciplinary Crossover Study |
Q47555114 | Expanded cardiac rehabilitation in socially vulnerable patients with myocardial infarction: a 10-year follow-up study focusing on mortality and non-fatal events |
Q53224035 | FIT@Home editorial: Supporting a new era of cardiac rehabilitation at home? |
Q39155453 | Gender differences in physical activity following acute myocardial infarction in adults: A prospective, observational study |
Q64261261 | High quality process of care increases one-year survival after acute myocardial infarction (AMI): A cohort study in Italy |
Q38670600 | Improving adherence to medication for secondary cardiovascular disease prevention |
Q38668879 | In the modern era of percutaneous coronary intervention: Is cardiac rehabilitation engagement purely a patient or a service level decision? |
Q57211271 | International Validation of the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Commi |
Q47917702 | Mediterranean diet and prognosis of first-diagnosed Acute Coronary Syndrome patients according to heart failure phenotype: Hellenic Heart Failure Study |
Q47902404 | Myocardial Infarction and Exercise Training: Evidence from Basic Science |
Q57284778 | Predicting Adherence to Internet-Delivered Psychotherapy for Symptoms of Depression and Anxiety After Myocardial Infarction: Machine Learning Insights From the U-CARE Heart Randomized Controlled Trial |
Q50141738 | Predictors of subsequent myocardial infarction, stroke, and death in stable post-myocardial infarction patients: A nationwide cohort study |
Q58777961 | Tailored nurse-led cardiac rehabilitation after myocardial infarction results in better risk factor control at one year compared to traditional care: a retrospective observational study |
Q92316609 | The difference in referencing in Web of Science, Scopus, and Google Scholar |
Q64057648 | The effect of an expanded long-term periodization exercise training on physical fitness in patients with coronary artery disease: study protocol for a randomized controlled trial |
Q96170639 | The pharmacology, toxicology and therapeutic potential of anthraquinone derivative emodin |
Q54270585 | Who needs secondary prevention? |
Q33610120 | Young adulthood cognitive ability predicts statin adherence in middle-aged men after first myocardial infarction: A Swedish National Registry study |
Search more.